Skip to main content

Advertisement

SpringerLink
Log in

Renoprotective effect of diosgenin in streptozotocin induced diabetic rats

  • Original research article
  • Published:
Pharmacological Reports Aims and scope Submit manuscript

Abstract

Background

Diabetes mellitus is a multifactorial metabolic disorder associated with genesis of diabetes related vascular diseases. Oxidative stress along with inflammation is the major causative factor leading to diabetic complications. The present study examined the protective effect of diosgenin, a steroidal saponin, in diabetes induced early kidney injury.

Methods

Diabetes was induced by streptozotocin (45 mg/kg) in rats followed by treatment for 28 days with diosgenin (5, 10 and 20 mg/kg, oral). Blood glucose levels, lipid profile, serum advanced glycation end-products, biomarkers of kidney damage like urinary protein excretion, kidney hypertrophy index and creatinine in serum and urine were determined. Biochemical analysis of oxidative stress parameters such as superoxide dismutase, catalase, reduced glutathione, lipid peroxidation (LPO) and myeloperoxidase level were evaluated in kidney homogenates. Histopathological evaluation of kidney was also studied.

Results

Treatment with diosgenin significantly ameliorated the altered oxidative stress levels in STZ induced diabetic rats resulting in decreased LPO and increased endogenous antioxidant levels in a dose-dependent manner. Blood glucose was significantly decreased at 20 mg/kg. The distorted levels of biomarkers suggestive of kidney damage were significantly normalized by diosgenin providing protection to kidneys also confirmed by histopathological studies. Decreased myeloperoxidase levels in diosgenin treatment groups revealed its anti-inflammatory activity.

Conclusion

The above study justifies diosgenin as a promising candidate in diabetes associated complication through its antioxidant and anti-inflammatory activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. World Health Organization. http://www.who.int/features/factfiles/diabetes/facts/en/index2.html [Accessed 09.05.15].

  2. Brownlee M. The pathobiology of diabetic complications — a unifying mechanism. Diabetes 2005;54(6):1615–25.

    Article  CAS  Google Scholar 

  3. Balakumar P, Arora MK, Ganti SS, Reddy J, Singh M. Recent advances in pharmacotherapy for diabetic nephropathy: current perspectives and future directions. Pharmacol Res 2009;60(1):24–32.

    Article  CAS  Google Scholar 

  4. Phillips AO. Diabetic nephropathy. Medicine 2011;39(8):470–4.

    Article  Google Scholar 

  5. Zhang J, Xie X, Li C, Fu P. Systematic review of the renal protective effect of Astragalus membranaceus (root) on diabetic nephropathy in animal models. J Ethnopharmacol 2009;126(2):189–96.

    Article  CAS  Google Scholar 

  6. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414(6865):813–20.

    Article  CAS  Google Scholar 

  7. Cerelio A, Ihnat MA, Thorpe JE. The “metabolic memory”: is more than just tight glucose control necessary to prevent diabetic complications? J Clin Endocrinol Metab 2009;94(2):410–5.

    Article  Google Scholar 

  8. Zheng L, Howell SJ, Hatala DA, Huang K, Kern TS. Salicylate-based anti-inflammatory drugs inhibit the early lesion of diabetic retinopathy. Diabetes 2007;56(2):337–45.

    Article  CAS  Google Scholar 

  9. Chiu J, Khan ZA, Farhangkhoee H, Chakrabarti S. Curcumin prevents diabetes-associated abnormalities in the kidneys by inhibiting p300 and nuclear factor-kappaB. Nutrition 2009;25(9):964–72.

    Article  CAS  Google Scholar 

  10. Ling C, Jinping L, Xia L, Renyong Y. Ursolic acid provides kidney protection in diabetic rats. Curr Ther Res Clin Exp 2013;75:59–63.

    Article  Google Scholar 

  11. Kanika P, Manoj G, Vijay T, Dinesh KP. A review on pharmacological and analytical aspects of diosgenin: a concise report. Nat Prod Bioprospect 2012; 2(2):46–52.

    Article  Google Scholar 

  12. Wang W, Liu S, Chang W, Shiue Y, Hsieh P, Hung T, et al. The effects of diosgenin in the regulation of renal proximal tubular fibrosis. Exp Cell Res 2014;323:255–62.

    Article  CAS  Google Scholar 

  13. Saha S, Goswami G, Pandrangi A. Isolation and prevention of calcium oxalate-induced apoptotic death and oxidative stress in MDCK cells by diosgenin. Chem Biol Interact 2014;224:51–7.

    Article  CAS  Google Scholar 

  14. Manivannan J, Bharathkumar TR, Sivasubramanian J, Arunagiri P, Raja B, Balamurugan E. Diosgenin attenuates vascular calcification in chronic renal failure rats. Mol Cell Biochem 2013;378(1–2):9–18.

    Article  CAS  Google Scholar 

  15. Liagre B, Bertrand J, Leger DY, Beneytout JL. Diosgenin, a plant steroid, induces apoptosis in COX-2 deficient K562 cells with activation of the p38 MAP kinase signalling and inhibition of NF-kappaB binding. Int J Mol Med 2005;16(6):1095–101.

    CAS  PubMed  Google Scholar 

  16. Waisundara VY, Hsu A, Tan BK, Huang D. Baicalin reduces mitochondrial damage in streptozotocin-induced diabetic Wistar rats. Diabetes Metab Res Rev 2009;25(7):671–7.

    Article  CAS  Google Scholar 

  17. Hargrove GM, Dufresne J, Whiteside C, Muruve DA, Wong NC. Diabetes mellitus increases endothelin-1 gene transcription in rat kidney. Kidney Int 2000;58(4):1534–45.

    Article  CAS  Google Scholar 

  18. Liu W, Zhang X, Liu P, Shen X, Lan T, Li W, et al. Effects of berberine on matrix accumulation and NF-kappa B signal pathway in alloxan-induced diabetic mice with renal injury. Eur J Pharmacol 2010;638(1–3):150–5.

    Article  CAS  Google Scholar 

  19. Patil SP, Jain PD, Sancheti JS, Ghumatkar PJ, Tambe R, Sathaye S. Neuroprotective and neurotrophic effects of apigenin and luteolin in MPTP induced parkinsonism in mice. Neuropharmacology 2014;86:192–202.

    Article  CAS  Google Scholar 

  20. Odobasic D, Kitching AR, Semple TJ, Holdsworth SR. Endogenous myeloperoxidase promotes neutrophil-mediated renal injury, but attenuates T cell immunity inducing crescentic glomerulonephritis. J Am Soc Nephrol 2007; 18(3):760–70.

    Article  CAS  Google Scholar 

  21. Münch G, Keis R, Wessels A, Riederer P, Bahner U, Heidland A, et al. Determination of advanced glycation end products in serum by fluorescence spectroscopy and competitive ELISA. Eur J Clin Chem Clin Biochem 1997; 35(9):669–77.

    PubMed  Google Scholar 

  22. Patel AN, Bandwane DD, Mhetre NK. Pomegranate (Punica granatum Linn.) leaves attenuate disturbed glucose homeostasis and hyperglycemia mediated hyperlipidemia and oxidative stress in streptozotocin induced diabetic rats. Eur J Integr Med 2014;6(3):307–21.

    Article  Google Scholar 

  23. Ghule AE, Jadhav SS, Bodhankar SL. Trigonelline ameliorates diabetic hypertensive nephropathy by suppression of oxidative stress in kidney and reduction in renal cell apoptosis and fibrosis in streptozotocin induced neonatal diabetic (nSTZ) rats. Int Immunopharmacol 2012;14(4):740–8.

    Article  CAS  Google Scholar 

  24. Wang GG, Lu XH, Li W, Zhao X, Zhang C. Protective effects of luteolin on diabetic nephropathy in STZ-induced diabetic rats. Evid Based Complement Altern Med 2011;2011:1–7.

    Google Scholar 

  25. Raghunathan S, Tank P, Bhadada S, Patel B. Evaluation of buspirone on streptozotocin induced type 1 diabetes and its associated complications. Biomed Res Int 2014;2014:1–9.

    Article  Google Scholar 

  26. Tzeng TF, Liou SS, Chang CJ, Liu IM. Zerumbone, a tropical ginger sesquiterpene, ameliorates streptozotocin-induced diabetic nephropathy in rats by reducing the hyperglycemia-induced inflammatory response. Nutr Metab 2013;10:1–12.

    Article  Google Scholar 

  27. Chen Jinglou, Lei Yongfang, Liu Yujie, Xiong Chaomei, Fu Wei, Ruan Jinlan. Extract of Cyclosorus acuminatus attenuates diabetic nephropathy in mice via modifying peroxisome proliferators activated receptor signalling pathway. Food Chem 2011;128(3):659–66.

    Article  Google Scholar 

  28. Jagtap AG, Shirke SS, Phadke AS. Effect of polyherbal formulation on experimental models of inflammatory bowel diseases. J Ethnopharmacol 2004;90:195–204.

    Article  CAS  Google Scholar 

  29. Rahbar S. Novel inhibitors of glycation and AGE formation. Cell Biochem Biophys 2007;48(2–3):147–57.

    Article  CAS  Google Scholar 

  30. Rahbar S, Figarola JL. Novel inhibitors ofadvanced glycation endproducts. Arch Biochem Biophys 2003;419(1):63–79.

    Article  CAS  Google Scholar 

  31. Banki E, Degrell P, Kiss P, Kovacs K, Kemeny A, Csanaky K, et al. Effect of PACAP treatment on kidney morphology and cytokine expression in rat diabetic nephropathy. Peptides 2013;42:125–30.

    Article  CAS  Google Scholar 

  32. Morsy MA, Ibrahim SA, Amin EF, Kamel MY, Abdelwahab SA, Hassan MK Carvedilol ameliorates early diabetic nephropathy in streptozotocin-induced diabetic rats. Biomed Res Int 2014;1–8.

Download references

Author information

Authors and Affiliations

  1. Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology (University Under Section-3 of UGC Act 1956), Mumbai, India

    Divya M. Kanchan, Gauresh S. Somani, Vaibhavi V. Peshattiwar, Aakruti A. Kaikini & Sadhana Sathaye

Authors
  1. Divya M. Kanchan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gauresh S. Somani
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Vaibhavi V. Peshattiwar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Aakruti A. Kaikini
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sadhana Sathaye
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sadhana Sathaye.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kanchan, D.M., Somani, G.S., Peshattiwar, V.V. et al. Renoprotective effect of diosgenin in streptozotocin induced diabetic rats. Pharmacol. Rep 68, 370–377 (2016). https://doi.org/10.1016/j.pharep.2015.10.011

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1016/j.pharep.2015.10.011

Keywords

Search

Navigation